We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Efforts to Integrate Clinical Trials Data into EHRs

By HospiMedica International staff writers
Posted on 21 Mar 2012
The US National Cancer Institute (NCI, Bethesda, MD, USA) is joining forces with Health Level Seven International (HL7, Ann Arbor, MI, USA) to connect trials data with electronic health records (EHRs), the group announced last month. More...


Talk of standards to make EHR systems interoperable with electronic data capture (EDC)-type data has taken place for several years, with little to show in the way of progress. But HL7 said that it plans to launch a pilot project in late 2012, with the ultimate goal of applying the same standards the group uses for packaging clinical care data to clinical trials data, which could then be used by doctors to assist in and tailor treatments for patients who have been involved in clinical research.

In general, pharmaceutical companies have applauded efforts to open pipelines between clinical trials systems and EHRs, which could provide them with a way to find patients that fit their drug trials electronically. Aiming to stay on the leading edge, Oracle (Redwood Shores, CA, USA) launched a health research platform that offers the ability to analyze clinical trials data alongside EHR data. The company is also providing the same technology for a pilot electronic research network progressing in New York State (USA) as part of the Partnerships to Advance Clinical Electronic Research (PACeR).

PACeR and other efforts have attracted government agencies, hospitals, pharmaceutical corporations, academic groups and tech providers to the table, as these parties all have a stake in speeding up the notoriously slow process of bringing new therapies to market. With patient and clinical trials data in electronic format and interoperable among different systems, the NCI and HL7 believe they can contribute to the goal.

HL7 is a non-profit standards development organization with affiliates established in more than 30 countries dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery, and evaluation of health services. HL7 has more than 2,300 members, representing approximately 500 corporate members, which include more than 90% of the information systems vendors serving healthcare.

Related Links:

US National Cancer Institute
Health Level Seven International
Oracle



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.